Literature DB >> 3799339

Hepatic microcirculation in Zucker fatty rats.

N Sato, H Eguchi, A Inoue, T Matsumura, S Kawano, T Kamada.   

Abstract

We have developed a microscopic analyzing system for studying in vivo hepatic microcirculation, and measured the sinusoidal erythrocyte flow velocity simultaneously in the various sinusoids. With this system and organ reflectance spectrophotometry, the pathophysiological role of microcirculation and of energy metabolism in Zucker fatty rats were studied. The results were as follows: The erythrocyte flow velocity in the predominant sinusoids in the fatty rats was similar to that of the control rats, but the intersinusoidal erythrocyte flow was undetected in the fatty liver. Index of regional hepatic blood volume, regional hepatic blood flow and oxygen saturation of Hb decreased significantly in the fatty rats. The estimated in vivo oxygen consumption was not changed in the fatty liver. From these data, it is concluded that in Zucker fatty rats a marked fatty infiltration causes a decreased hepatic tissue blood flow and volume, but relatively homogeneous erythrocyte flow with an increased extraction of oxygen compensated the decreased vascular beds and maintained normal energy metabolism.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3799339     DOI: 10.1007/978-1-4684-5188-7_59

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  8 in total

1.  Contrast-Based Real-Time Assessment of Microcirculatory Changes in a Fatty Liver After Ischemia Reperfusion Injury.

Authors:  Vasantha L Kolachala; Rong Jiang; Carlos R Abramowsky; Nitika A Gupta
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-03       Impact factor: 2.839

Review 2.  Steatosis as a risk factor in liver surgery.

Authors:  Reeta Veteläinen; Arlène van Vliet; Dirk J Gouma; Thomas M van Gulik
Journal:  Ann Surg       Date:  2007-01       Impact factor: 12.969

3.  Type 2 diabetic patients with non-alcoholic fatty liver disease exhibit significant haemorheological abnormalities.

Authors:  Hui Dong; Fu'er Lu; Nan Wang; Xin Zou; Jingjing Rao
Journal:  Front Med       Date:  2011-10-02       Impact factor: 4.592

4.  Limited therapeutic efficacy of thrombopoietin on the regeneration of steatotic livers.

Authors:  Kerstin Abshagen; Franziska Mertens; Christian Eipel; Brigitte Vollmar
Journal:  Int J Clin Exp Pathol       Date:  2013-08-15

5.  Vitamin E succinate reduces ischemia/reperfusion injury in steatotic livers.

Authors:  Z P Evans; J D Ellett; M W Fariss; R G Schnellmann; M G Schmidt; K Chavin
Journal:  Transplant Proc       Date:  2008-12       Impact factor: 1.066

6.  Xenon computed tomography can evaluate the improvement of hepatic hemodynamics before and after endoscopic injection sclerotherapy.

Authors:  Hideaki Takahashi; Michihiro Suzuki; Ryuta Shigefuku; Miki Okano; Tetsuya Hiraishi; Rei Takagi; Yohei Noguchi; Nobuhiro Hattori; Moriaki Hatsugai; Kazunari Nakahara; Masaru Okamoto; Minoru Kobayashi; Hiroki Ikeda; Yasunobu Fukuda; Yoshihiko Nagase; Toshiya Ishii; Kotaro Matsunaga; Nobuyuki Matsumoto; Chiaki Okuse; Shigeru Sase; Fumio Itoh
Journal:  J Gastroenterol       Date:  2013-02-09       Impact factor: 7.527

Review 7.  Autophagy in the liver: cell's cannibalism and beyond.

Authors:  Joseph A Flores-Toro; Kristina L Go; Christiaan Leeuwenburgh; Jae-Sung Kim
Journal:  Arch Pharm Res       Date:  2016-08-11       Impact factor: 4.946

8.  Liver fat content in type 2 diabetes: relationship with hepatic perfusion and substrate metabolism.

Authors:  Luuk J Rijzewijk; Rutger W van der Meer; Mark Lubberink; Hildo J Lamb; Johannes A Romijn; Albert de Roos; Jos W Twisk; Robert J Heine; Adriaan A Lammertsma; Johannes W A Smit; Michaela Diamant
Journal:  Diabetes       Date:  2010-08-06       Impact factor: 9.461

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.